Interaction of amyloid beta with humanin and acetylcholinesterase is modulated by ATP

被引:19
作者
Atali, Sarah [1 ]
Dorandish, Sadaf [1 ]
Devos, Jonathan [1 ]
Williams, Asana [1 ]
Price, Deanna [1 ]
Taylor, Jaylen [1 ]
Guthrie, Jeffrey [1 ]
Heyl, Deborah [1 ]
Evans, Hedeel Guy [1 ]
机构
[1] Eastern Michigan Univ, Chem Dept, Ypsilanti, MI 48197 USA
来源
FEBS OPEN BIO | 2020年 / 10卷 / 12期
基金
美国国家卫生研究院;
关键词
acetylcholinesterase; amyloid‐ beta; humanin; kinetics; lung cancer; peptide interaction; NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; NEUROPROTECTIVE FACTOR; PEPTIDE MODULATORS; OLIGOMER FORMATION; MASS-SPECTROMETRY; EXTRACELLULAR ATP; IN-VITRO; CANCER; AGGREGATION;
D O I
10.1002/2211-5463.13023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Humanin (HN) is known to bind amyloid beta (A beta)-inducing cytoprotective effects, while binding of acetylcholinesterase (AChE) to A beta increases its aggregation and cytotoxicity. Previously, we showed that binding of HN to A beta blocks aggregation induced by AChE and that HN decreases but does not abolish A beta-AChE interactions in A549 cell media. Here, we set out to shed light on factors that modulate the interactions of A beta with HN and AChE. We found that binding of either HN or AChE to A beta is not affected by heparan sulfate, while ATP, thought to reduce misfolding of A beta, weakened interactions between AChE and A beta but strengthened those between A beta and HN. Using media from either A549 or H1299 lung cancer cells, we observed that more HN was bound to A beta upon addition of ATP, while levels of AChE in a complex with A beta were decreased by ATP addition to A549 cell media. Exogenous addition of ATP to either A549 or H1299 cell media increased interactions of endogenous HN with A beta to a comparable extent despite differences in AChE expression in the two cell lines, and this was correlated with decreased binding of exogenously added HN to A beta. Treatment with exogenous ATP had no effect on cell viability under all conditions examined. Exogenously added ATP did not affect viability of cells treated with AChE-immunodepleted media, and there was no apparent protection against the cytotoxicity resulting from immunodepletion of HN. Moreover, exogenously added ATP had no effect on the relative abundance of oligomer versus total A beta in either cell line.
引用
收藏
页码:2805 / 2823
页数:19
相关论文
共 106 条
  • [1] Solution NMR structure and inhibitory effect against amyloid-β fibrillation of Humanin containing a D-isomerized serine residue
    Alsanousi, Nesreen
    Sugiki, Toshihiko
    Furuita, Kyoko
    So, Masatomo
    Lee, Young-Ho
    Fujiwara, Toshimichi
    Kojima, Chojiro
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 477 (04) : 647 - 653
  • [2] Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils
    Alvarez, A
    Opazo, C
    Alarcon, R
    Garrido, J
    Inestrosa, NC
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 272 (03) : 348 - 361
  • [3] Homogeneous and Heterogeneous Tertiary Structure Ensembles of Amyloid-β Peptides
    Ball, K. Aurelia
    Phillips, Aaron H.
    Nerenberg, Paul S.
    Fawzi, Nicolas L.
    Wemmer, David E.
    Head-Gordon, Teresa
    [J]. BIOCHEMISTRY, 2011, 50 (35) : 7612 - 7628
  • [4] SOLUTION STRUCTURES OF BETA PEPTIDE AND ITS CONSTITUENT FRAGMENTS - RELATION TO AMYLOID DEPOSITION
    BARROW, CJ
    ZAGORSKI, MG
    [J]. SCIENCE, 1991, 253 (5016) : 179 - 182
  • [5] β-amyloid aggregation induced by human acetylcholinesterase:: inhibition studies
    Bartolini, M
    Bertucci, C
    Cavrini, V
    Andrisano, V
    [J]. BIOCHEMICAL PHARMACOLOGY, 2003, 65 (03) : 407 - 416
  • [6] Structure of the 21-30 fragment of amyloid β-protein
    Baumketner, Andrij
    Bernstein, Summer L.
    Wyttenbach, Thomas
    Lazo, Noel D.
    Teplow, David B.
    Bowers, Michael T.
    Shea, Joan-Emma
    [J]. PROTEIN SCIENCE, 2006, 15 (06) : 1239 - 1247
  • [7] Alzheimer's Disease Drug Development: Old Problems Require New Priorities
    Becker, Robert E.
    Greig, Nigel H.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2008, 7 (06) : 499 - 511
  • [8] A Common Biological Mechanism in Cancer and Alzheimer's Disease?
    Behrens, M. I.
    Lendon, C.
    Roe, C. M.
    [J]. CURRENT ALZHEIMER RESEARCH, 2009, 6 (03) : 196 - 204
  • [9] Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity
    Benaki, D
    Zikos, C
    Evangelou, A
    Livaniou, E
    Vlassi, M
    Mikros, E
    Pelecanou, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (01) : 152 - 160
  • [10] The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
    Benilova, Iryna
    Karran, Eric
    De Strooper, Bart
    [J]. NATURE NEUROSCIENCE, 2012, 15 (03) : 349 - 357